Ulinastatin Therapy in Kawasaki Disease

[1]  T. Akagi,et al.  Salicylate treatment in Kawasaki disease: high dose or low dose? , 1991, European Journal of Pediatrics.

[2]  M. Mori,et al.  Predictors of coronary artery lesions after intravenous γ-globulin treatment in Kawasaki disease , 2000 .

[3]  S. Miyazaki,et al.  Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. , 2000, The Journal of infectious diseases.

[4]  I. Sekine,et al.  The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. , 1999, The Journal of infectious diseases.

[5]  T. Satoh,et al.  Effects of Intravenous Gamma globulin and Ulinastatin on Patients with Kawasaki Disease and Predicted Giant Coronary Artery Aneurysms , 1997 .

[6]  M. Freed,et al.  Special Report Diagnosis and Therapy of Kawasaki Disease in Children , 1993, Circulation.

[7]  K. Harada.  Intravenous γ‐Globulin Treatment in Kawasaki Disease , 1991 .

[8]  K. Ishida,et al.  Pulmonary hypertension and polymorphonuclear leukocyte elastase after esophageal cancer operations. , 1991, Annals of Thoracic Surgery.

[9]  K. Akashi,et al.  Human urinary proteinase inhibitor in the treatment of P carinii pneumonia. , 1991, Chest.

[10]  D. Fulton,et al.  Effects of current therapy of Kawasaki disease on eicosanoid metabolism. , 1988, The American journal of cardiology.

[11]  S. Nishibe,et al.  Effect of human urinary trypsin inhibitor on granulocyte elastase activity. , 1987, Research communications in chemical pathology and pharmacology.

[12]  S. Daniels,et al.  Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. , 1986, Journal of the American College of Cardiology.

[13]  H. Nakano,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE , 1983, The Lancet.

[14]  M. Muramatu,et al.  Purification and characterization of urinary trypsin inhibitor, UTI68, from normal human urine, and its cleavage by human uropepsin. , 1980, Journal of biochemistry.